BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38698465)

  • 1. Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
    Lengacher NA; Tomlinson JJ; Jochum AK; Franz J; Hasan Ali O; Flatz L; Jochum W; Penninger J; ; Stadelmann C; Woulfe JM; Schlossmacher MG
    Acta Neuropathol Commun; 2024 May; 12(1):70. PubMed ID: 38698465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
    Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
    Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
    Carmona-Abellan M; Martinez-Valbuena I; Marcilla I; DiCaudo C; Gil I; Nuñez J; Luquin MR
    Neurol Sci; 2021 Apr; 42(4):1473-1482. PubMed ID: 32816165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
    Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW
    Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
    Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
    Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
    Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
    Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb.
    Sengoku R; Saito Y; Ikemura M; Hatsuta H; Sakiyama Y; Kanemaru K; Arai T; Sawabe M; Tanaka N; Mochizuki H; Inoue K; Murayama S
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1072-83. PubMed ID: 18957894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between cortical and subcortical tau pathology.
    Attems J; Thomas A; Jellinger K
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.
    Flores-Cuadrado A; Saiz-Sanchez D; Mohedano-Moriano A; Martinez-Marcos A; Ubeda-Bañon I
    Acta Neuropathol Commun; 2019 Apr; 7(1):56. PubMed ID: 30987677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe.
    Mason DM; Nouraei N; Pant DB; Miner KM; Hutchison DF; Luk KC; Stolz JF; Leak RK
    Mol Neurodegener; 2016 Jun; 11(1):49. PubMed ID: 27363576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of olfactory bulb pathology on olfactory function in normal aging.
    Tremblay C; Serrano GE; Intorcia AJ; Sue LI; Wilson JR; Adler CH; Shill HA; Driver-Dunckley E; Mehta SH; Beach TG
    Brain Pathol; 2022 Sep; 32(5):e13075. PubMed ID: 35485279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology.
    Calderón-Garcidueñas L; González-Maciel A; Reynoso-Robles R; Kulesza RJ; Mukherjee PS; Torres-Jardón R; Rönkkö T; Doty RL
    Environ Res; 2018 Oct; 166():348-362. PubMed ID: 29935448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
    Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
    Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
    Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.